JP2022548876A5 - - Google Patents
Info
- Publication number
- JP2022548876A5 JP2022548876A5 JP2022516412A JP2022516412A JP2022548876A5 JP 2022548876 A5 JP2022548876 A5 JP 2022548876A5 JP 2022516412 A JP2022516412 A JP 2022516412A JP 2022516412 A JP2022516412 A JP 2022516412A JP 2022548876 A5 JP2022548876 A5 JP 2022548876A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025011057A JP2025081331A (ja) | 2019-09-12 | 2025-01-27 | 嗜癖の治療および／または予防を必要とする対象の嗜癖の治療および／または予防におけるシチシンを含む組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962899637P | 2019-09-12 | 2019-09-12 | |
| US62/899,637 | 2019-09-12 | ||
| US202062988890P | 2020-03-12 | 2020-03-12 | |
| US62/988,890 | 2020-03-12 | ||
| PCT/US2020/046308 WO2021050203A1 (en) | 2019-09-12 | 2020-08-14 | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011057A Division JP2025081331A (ja) | 2019-09-12 | 2025-01-27 | 嗜癖の治療および／または予防を必要とする対象の嗜癖の治療および／または予防におけるシチシンを含む組成物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022548876A JP2022548876A (ja) | 2022-11-22 |
| JP2022548876A5 true JP2022548876A5 (https=) | 2023-08-23 |
| JPWO2021050203A5 JPWO2021050203A5 (https=) | 2023-08-23 |
| JP7742832B2 JP7742832B2 (ja) | 2025-09-22 |
Family
ID=74866435
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516412A Active JP7742832B2 (ja) | 2019-09-12 | 2020-08-14 | 嗜癖の治療および／または予防を必要とする対象の嗜癖の治療および／または予防におけるシチシンを含む組成物 |
| JP2025011057A Pending JP2025081331A (ja) | 2019-09-12 | 2025-01-27 | 嗜癖の治療および／または予防を必要とする対象の嗜癖の治療および／または予防におけるシチシンを含む組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011057A Pending JP2025081331A (ja) | 2019-09-12 | 2025-01-27 | 嗜癖の治療および／または予防を必要とする対象の嗜癖の治療および／または予防におけるシチシンを含む組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11083715B2 (https=) |
| EP (1) | EP4027815B1 (https=) |
| JP (2) | JP7742832B2 (https=) |
| KR (1) | KR20220074895A (https=) |
| CN (4) | CN119587493A (https=) |
| AU (1) | AU2020346695A1 (https=) |
| BR (1) | BR112022004519A2 (https=) |
| CA (1) | CA3153405A1 (https=) |
| MX (1) | MX2022002882A (https=) |
| WO (1) | WO2021050203A1 (https=) |
| ZA (1) | ZA202204075B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3153405A1 (en) * | 2019-09-12 | 2021-03-18 | Achieve Life Sciences, Inc. | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
| EP4399517A4 (en) * | 2021-09-08 | 2025-10-15 | Achieve Life Sciences Inc | ANALYTICAL METHODS FOR EVALUATING THE PURITY OF CYTISINE |
| JP2024095092A (ja) * | 2022-12-28 | 2024-07-10 | 株式会社日立製作所 | 生成装置、生成方法、および生成プログラム |
| WO2024226736A2 (en) * | 2023-04-26 | 2024-10-31 | Achieve Life Sciences, Inc. | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2125699B (en) | 1982-02-22 | 1986-02-12 | Bruss Ni Sanitarno Gigieniches | Medicinal preparation having antinicotine effect and method for obtention thereof |
| WO1998018798A1 (en) * | 1996-10-30 | 1998-05-07 | Pfizer Inc. | Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| AR044007A1 (es) * | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
| CN104906669A (zh) * | 2007-03-30 | 2015-09-16 | 菲利普莫里斯生产公司 | 用于输送药剂的装置和方法 |
| CN103284319A (zh) * | 2013-06-20 | 2013-09-11 | 昌宁德康生物科技有限公司 | 一种金雀花碱替代尼古丁口腔雾化液及其制备方法 |
| WO2014205449A2 (en) * | 2013-06-21 | 2014-12-24 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating apolipoprotein c-iii expression for improving a diabetic profile |
| JP6324964B2 (ja) | 2013-08-23 | 2018-05-16 | 久光製薬株式会社 | 貼付剤 |
| PL409829A1 (pl) * | 2014-10-18 | 2016-04-25 | Łukasz Zalewski | Płyn z cytyzyną do elektronicznych papierosów |
| GB201602145D0 (en) * | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
| EP3658561A1 (en) * | 2017-07-24 | 2020-06-03 | Achieve Pharma UK Limited | Cytisine salts |
| CA3153405A1 (en) * | 2019-09-12 | 2021-03-18 | Achieve Life Sciences, Inc. | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
-
2020
- 2020-08-14 CA CA3153405A patent/CA3153405A1/en active Pending
- 2020-08-14 CN CN202411683584.7A patent/CN119587493A/zh active Pending
- 2020-08-14 MX MX2022002882A patent/MX2022002882A/es unknown
- 2020-08-14 CN CN202411684617.XA patent/CN119564619A/zh active Pending
- 2020-08-14 US US16/993,522 patent/US11083715B2/en active Active
- 2020-08-14 CN CN202080064060.3A patent/CN114727647A/zh active Pending
- 2020-08-14 CN CN202410180790.XA patent/CN118286217A/zh active Pending
- 2020-08-14 AU AU2020346695A patent/AU2020346695A1/en active Pending
- 2020-08-14 JP JP2022516412A patent/JP7742832B2/ja active Active
- 2020-08-14 BR BR112022004519A patent/BR112022004519A2/pt unknown
- 2020-08-14 EP EP20862843.8A patent/EP4027815B1/en active Active
- 2020-08-14 KR KR1020227012082A patent/KR20220074895A/ko active Pending
- 2020-08-14 WO PCT/US2020/046308 patent/WO2021050203A1/en not_active Ceased
- 2020-11-23 US US17/101,686 patent/US11083716B2/en active Active
-
2021
- 2021-07-02 US US17/366,497 patent/US20210330652A1/en not_active Abandoned
-
2022
- 2022-04-11 ZA ZA2022/04075A patent/ZA202204075B/en unknown
-
2025
- 2025-01-27 JP JP2025011057A patent/JP2025081331A/ja active Pending